10
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Impact of COVID-19 on pediatric asthma: practice adjustments and disease burden.

      research-article
      , MD, PhD, FRCP, FAAAAI 1 , 2 , # , , MSc, DM, MD, PhD, FRCP 3 , , MD 4 , , MD, MRCP(UK) 1 , 5 , , MD, MS 6 , , MD, FRCPC, FHKAM 7 , , MD, PhD 2 , , MD 8 , , MD 9 , , MD, PhD 10 , 11 , , MD 12 , , MD, PhD 13 , , MD 14 , , MD, M.Sc., FRCPC 15 , , MD, PhD 16 , , MD 17 , , MD 18 , , MD, PhD 19 , 20 , , MD 21 , , MD 22 , , MD, PhD 23 , 24 , , MD, PhD 25 , , MD, PhD 26 , , MD, PhD, FAAAAI 27 , , MD 28 , , MD 29 , , MD, CCFP(EM), FCFP 30 , , MD, PhD 31 , 32 , , MD, PhD 33 , , MD, PhD 34 , , MBBS FRACP FERS MD 35 , , MD FAAAAI 36 , , MD, PhD 37 , , MD, MSc, PhD 38 , , MBChB, MD, MRCP, MRCPHCH 39 , , MD 40 , , MD, PhD 41 , , MD, PhD 42 , , MD 43 , , MD, PhD 44 , , MD, PhD, FCCP 45 , , MD 46 , 47 , , DM, FRCPCH, MA, MSc 48 , , MD, PhD 49 , , MD, PhD 50 , PeARL collaborators
      The Journal of Allergy and Clinical Immunology. in Practice
      Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
      asthma, child, virus, adherence, COVID-19, SARS-CoV2, control, 99% CI, 99% Confidence intervals, ACE2, Angiotensin converting enzyme 2, ACQ, Asthma Control Questionnaire, ACT, Asthma Control Test, COVID-19, Coronavirus Disease 2010, FeNO, Fractional Exhaled Nitric Oxide, IQR, Interquartile range, PeARL, Pediatric Asthma in Real Life, PEFR, Peak expiratory flow rate, REG, Respiratory Effectiveness Group, RR, Relative risk, SARS-CoV2, Severe Acute Respiratory Syndrome Coronavirus 2, WAO, World Allergy Organization

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          It is unclear whether asthma may affect susceptibility or severity of the Coronavirus Disease 2019 (COVID-19) in children and how pediatric asthma services worldwide have responded to the pandemic.

          Objective

          To describe the impact of the COVID-19 pandemic on pediatric asthma services and on disease burden in their patients.

          Methods

          An online survey was sent to members of the Pediatric Asthma in Real Life (PeARL) think-tank and the World Allergy Organization Pediatric Asthma Committee. It included questions on service provision, disease burden and on the clinical course of confirmed cases of COVID-19 infection among children with asthma.

          Results

          Ninety-one respondents, caring for an estimated population of >133,000 children with asthma, completed the survey. COVID-19 significantly impacted pediatric asthma services: 39% ceased physical appointments, 47% stopped accepting new patients, 75% limited patients visits. Consultations were almost halved to a median of 20 (IQR: 10-25) patients per week. Virtual clinics and helplines were launched in most centers. Better than expected disease control was reported in 20% (10-40%) of patients, while control was negatively affected in only 10% (7.5-12.5%). Adherence also appeared to increase. Only 15 confirmed cases of COVID-19 were reported among the population; the estimated incidence is not apparently different from the reports of general pediatric cohorts.

          Conclusion

          Children with asthma do not appear to be disproportionately affected by COVID-19. Outcomes may even have improved, possibly through increased adherence and/or reduced exposures. Clinical services have rapidly responded to the pandemic by limiting and replacing physical appointments with virtual encounters.

          Highlights box

          • What is already known about this topic?

          • COVID-19 has a mild disease course in children and adolescents. Chronic respiratory conditions, including asthma, have been suggested as risk factors, however, asthma in children is highly variable in both triggers and severity.

          • What does this article add to our knowledge?

          • During the pandemic, pediatric asthma services limited consultations and established virtual clinics. However, respondents perceived their patients’ asthma control to be retained or even improved, while treatment adherence was considered increased. Children with asthma were not disproportionately affected by COVID-19.

          • How does this study impact current management guidelines?

          • Trigger avoidance and treatment adherence can rapidly improve asthma control in children, even under lockdown pressure. Children/adolescents with asthma do not appear to need additional prophylactic measures from COVID-19 when asthmais well-treated.

          Related collections

          Author and article information

          Contributors
          Journal
          J Allergy Clin Immunol Pract
          J Allergy Clin Immunol Pract
          The Journal of Allergy and Clinical Immunology. in Practice
          Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
          2213-2198
          2213-2201
          17 June 2020
          17 June 2020
          Affiliations
          [1 ]Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK
          [2 ]Allergy Department, 2nd Paediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece
          [3 ]Department of Paediatrics, Imperial College London, London, UK
          [4 ]Pediatric Pulmonology and Allergy Department, Hôpital Jeanne de Flandre, CHU Lille, France
          [5 ]North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
          [6 ]Children's Hospital Boston, Pediatric Allergy and Immunology, Boston, Massachusetts, USA
          [7 ]Department of Pediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong
          [8 ]Allergy & Clinical Immunology, Transylvania University, Brasov, Romania
          [9 ]Division of Allergy, Immunology and Pulmonary Medicine Washington
          [10 ]Department of Cardiovascular and Thoracic Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli – IRCCS, Rome, Italy
          [11 ]National Heart and Lung Institute (NHLI), Imperial College London, UK
          [12 ]Division of Pediatrics, School of Medicine, Pontificia Universidad Catolica de Chile
          [13 ]Pulmonology Department, Children’s Hospital Zhejiang University School of Medicine
          [14 ]Department of Allergy and Immunology, Penn State University, State College, PA, USA
          [15 ]Department of Pediatrics, University of Montreal, Department of Social and Preventive Medicine, University of Montreal
          [16 ]Pediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt
          [17 ]Department of Department of Pediatric Respiratory Diseases and Allergy, The Medical University of Warsaw, Poland
          [18 ]Allergy Department, Bambino Gesù Children’s Hospital, Roma – Italy
          [19 ]Pediatric Respiratory and Allergy Units, “Virgen de la Arrixaca” Children's University Clinical Hospital, University of Murcia
          [20 ]Institute for Biomedical Research of Murcia, IMIB-Arrixaca; & Network of Asthma and Adverse and Allergic Reactions (ARADyAL)
          [21 ]Department of Pediatrics and Medicine, University of Wisconsin School of Medicine and Public Health, Madison, USA
          [22 ]Department of Internal Medicine, Rush Medical College
          [23 ]Head, Research & Education, Ayre Foundation. Salta, Argentina
          [24 ]Consultant, Allergy & Asthma Dept, Alas Medical Institute. Salta
          [25 ]Children’s Center Bethel, EvKB, University Bielefeld, Germany
          [26 ]Paediatric Allergy, Centre for Allergy Research, Karolinska Institutet, Sweden
          [27 ]Pediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt
          [28 ]Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Finland
          [29 ]Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Ankara, Turkey
          [30 ]Chair Family Physician Airways Group of Canada
          [31 ]Astrid Lindgren Children´s Hospital, Karolinska University Hospital, Stockholm, Sweden
          [32 ]Department of Women´s and Children´s Health, Karolinska Institutet, Stockholm, Sweden
          [33 ]Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Poland
          [34 ]Charité Universitätsmedizin Berlin, Pediatric Pulmonology, Immunology and Intensive Care Medicine, Germany
          [35 ]School of Paediatrics & Child Health, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia
          [36 ]Departments of Pediatrics and Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis
          [37 ]Department of Allergy, Helsinki University Central Hospital, Finland
          [38 ]Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal
          [39 ]Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, UK
          [40 ]VN Allergy & Asthma Research Centre, Chennai, Tamilnadu, India
          [41 ]Head of the pediatric department in Pirogov Russian National Research Medical University of the Ministry of Health of the Russian
          [42 ]Pediatric Pulmonology & Allergy Unit Children’s Hospital la Fe, Spain
          [43 ]Allergy and Respiratory Research Group, Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK
          [44 ]Pediatric Pulmonology Division, Hospital Moinhos de Vento
          [45 ]Pediatric Pulmonology, Pediatric Department, 2nd Faculty of Medicine, Charles University, Prague, University Hospital Motol, Prague, Czech Republic
          [46 ]Teaching and Research Department and Paediatric Allergy department, Hospital with Specialties Juan María de Salvatierra, La Paz, Baja California Sur México
          [47 ]Allergy & immunology Department Hospital Infantil de Medico Federico Gomez, Mexico city
          [48 ]Paediatric Allergy and Respiratory Medicine within Medicine at the University of Southampton
          [49 ]Clinic of Children's Diseases, Institute of Clinical Medicine, Medical Faculty of Vilnius University, Vilnius, Lithuania
          [50 ]Department of Pediatrics & Child Health, Director MRC Unit on Child & Adolescent Health, Red Cross War Memorial Children’s Hospital, University of Cape Town
          Author notes
          [# ]Corresponding Author: Professor Nikolaos G. Papadopoulos, Division of Infection, Immunity & Respiratory Medicine, The University of Manchester, Manchester UK. and Allergy Department, 2nd Paediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece. Phone: +30 210 7776964 ngpallergy@ 123456gmail.com
          Article
          S2213-2198(20)30599-7
          10.1016/j.jaip.2020.06.001
          7297686
          32561497
          a5ffa5fc-31dd-4d62-98f4-26e8dce110ce
          © 2020 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          History
          : 8 May 2020
          : 25 May 2020
          : 1 June 2020
          Categories
          Article

          asthma,child,virus,adherence,covid-19,sars-cov2,control,99% ci, 99% confidence intervals,ace2, angiotensin converting enzyme 2,acq, asthma control questionnaire,act, asthma control test,covid-19, coronavirus disease 2010,feno, fractional exhaled nitric oxide,iqr, interquartile range,pearl, pediatric asthma in real life,pefr, peak expiratory flow rate,reg, respiratory effectiveness group,rr, relative risk,sars-cov2, severe acute respiratory syndrome coronavirus 2,wao, world allergy organization

          Comments

          Comment on this article

          scite_
          0
          0
          0
          0
          Smart Citations
          0
          0
          0
          0
          Citing PublicationsSupportingMentioningContrasting
          View Citations

          See how this article has been cited at scite.ai

          scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

          Similar content190

          Cited by71